Publication

Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer

Kopetz, S
; 
Grothey, A
; 
Yaeger, R
; 
Van, CE
; 
Desai, J
; 
Yoshino, T
; 
Wasan, H
; 
Ciardiello, F
; 
Loupakis, F
; 
Hong, YS
... show 10 more
Citations
Altmetric:
Abstract
Authors
Kopetz, S
Grothey, A
Yaeger, R
Van, CE
Desai, J
Yoshino, T
Wasan, H
Ciardiello, F
Loupakis, F
Hong, YS
Steeghs, N
Guren, TK
Arkenau, HT
Garcia-Alfonso, P
Pfeiffer, P
Orlov, S
Lonardi, S
Elez, E
Kim, TW
Schellens, JHM
Guo, C
Krishnan, A
Dekervel, J
Morris, V
Calvo, FA
Tarpgaard, LS
Braun, Michael S
Gollerkeri, A
Keir, C
Maharry, K
Pickard, M
Christy-Bittel, J
Anderson, L
Sandor, V
Tabernero, J
Affiliation
University of Texas M.D. Anderson Cancer Center, Houston
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
Kopetz S, Grothey A, Yaeger R, Van Cutsem E, Desai J, Yoshino T, et al. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N Engl J Med. 2019;381(17):1632-43.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622411
Embedded videos